Please login to the form below

Not currently logged in
Email:
Password:

AUTO1

This page shows the latest AUTO1 news and features for those working in and with pharma, biotech and healthcare.

CAR-T player Autolus seeks $100m from follow-on financing

CAR-T player Autolus seeks $100m from follow-on financing

It is earmarking $125m to continue the clinical development of its pipeline, headed by CD19-targeted CAR-T therapy AUTO1 in adult acute lymphoblastic leukaemia (ALL) – a rival to Novartis’ ... Autolus is planning a pivotal trial of AUTO1, which it

Latest news

  • Autolus’ next-gen CAR-T looks promising in ALL Autolus’ next-gen CAR-T looks promising in ALL

    Autolus is hoping that AUTO1 will change that, and its first wave of data from that programme found it compared favourably to other CAR-T therapies in adult ALL. ... For comparison purposes, Yescarta also had a 23% severe CRS rate, and a 39% grade 3

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...
Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...

Infographics